Ornithine lipid is a partial TLR4 agonist and NLRP3 activator
Cell Reports · 2024
DOI: 10.1016/j.celrep.2024.114788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Malvina Pizzuto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Inflammation Group, Biomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain; Structure and Function of Biological Memb…. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, NLR Family, Pyrin Domain-Containing 3 Protein, Lipopolysaccharides, Macrophages. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council, Ministerio de Economía y Competitividad, Fund for Scientific Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Inflammation Group, Biomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain; Structure and Function of Biological Membranes Laboratory, Université Libre de Bruxelles, 1050 Brussels, Belgiu…
- Molecular Inflammation Group, Biomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain.
- Department of Pharmacognosy, Bioanalysis and Drug Discovery, Faculty of Pharmacy, Université Libre De Bruxelles, 1050 Brussels, Belgium.
- Structure and Function of Biological Membranes Laboratory, Université Libre de Bruxelles, 1050 Brussels, Belgium.
- Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4067, Australia.
- Molecular Inflammation Group, Biomedical Research Institute of Murcia (IMIB-Arrixaca), 30120 Murcia, Spain; Department of Biochemistry and Molecular Biology B and Immunology, Faculty of Medicine, University of Murcia, 3…
Förderung
- National Health and Medical Research Council
- Ministerio de Economía y Competitividad
- Fund for Scientific Research
- European Research Council
- HORIZON EUROPE European Research Council
- Ministerio de Ciencia e Innovación
- Fundacion Seneca
Zitieren
APA
Pizzuto, M., Hurtado-Navarro, L., Molina-Lopez, C., Soubhye, J., Gelbcke, M., Rodriguez-Lopez, S., Ruysschaert, J. M., Schroder, K., & Pelegrin, P. (2024). Ornithine lipid is a partial TLR4 agonist and NLRP3 activator. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114788
Vancouver
Pizzuto M, Hurtado-Navarro L, Molina-Lopez C, Soubhye J, Gelbcke M, Rodriguez-Lopez S, et al. Ornithine lipid is a partial TLR4 agonist and NLRP3 activator. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114788
BibTeX
@article{Pizzuto2024,
author = {Pizzuto, Malvina and Hurtado-Navarro, Laura and Molina-Lopez, Cristina and Soubhye, Jalal and Gelbcke, Michel and Rodriguez-Lopez, Silvia and Ruysschaert, Jean-Marie and Schroder, Kate and Pelegrin, Pablo},
title = {Ornithine lipid is a partial TLR4 agonist and NLRP3 activator},
journal = {Cell Reports},
year = {2024},
doi = {10.1016/j.celrep.2024.114788}
}
EUVIMED